scispace - formally typeset
D

Dan L. Longo

Researcher at Harvard University

Publications -  730
Citations -  59268

Dan L. Longo is an academic researcher from Harvard University. The author has contributed to research in topics: Antigen & Immune system. The author has an hindex of 125, co-authored 697 publications receiving 56085 citations. Previous affiliations of Dan L. Longo include University of Nebraska Omaha & Yale Cancer Center.

Papers
More filters
Journal Article

Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study.

TL;DR: ProMACE-CytaBOM plus anti-B4-blocked ricin does not produce durable complete remissions in the majority of patients with indolent lymphoma, however, the remissions appear quite durable (> 4 years) in about 40% of the complete responders.
Journal ArticleDOI

Macrophage Checkpoint Blockade in Cancer - Back to the Future.

TL;DR: Macrophages are an essential component of the tumor microenvironment and have been ascribed a role in cancer-promoting inflammation.
Journal ArticleDOI

A Phase I Trial of B7-Transfected or Parental Lethally Irradiated Allogeneic Melanoma Cell Lines to Induce Cell-Mediated Immunity Against Tumor-Associated Antigen Presented by HLA-A2 or HLA-A1 in Patients with Stage IV Melanoma. National Institutes of Health, Bethesda, Maryland

TL;DR: A phase I trial of B7-transfected allogeneic melanoma cell lines to induce cell-mediated immunity against tumor-associated antigens presented by HLA-A2 or Hla-A1 in patients with stage IV melanoma.
Journal ArticleDOI

Hck expression correlates with granulocyte-macrophage colony- stimulating factor-induced proliferation in HL-60 cells

TL;DR: Results show that cytokine receptors can exist in an uncoupled form and suggest that in HL-60 cells, appropriate levels of the src-like tyrosine kinase hck are critical for functional coupling of the GM-CSFR to biologic responses.
Journal ArticleDOI

The Antineoplastic Agent Bryostatin-1 Induces Proinflammatory Cytokine Production in Human Monocytes: Synergy With Interleukin-2 and Modulation of Interleukin-2Rγ Chain Expression

TL;DR: It is demonstrated that bryo-1 can potently induce the production of pro-inflammatory cytokines from human peripheral blood monocytes and suggests that stimulation of monokine secretion by bryO-1 may represent at least one of the mechanisms responsible for the in vivo antitumor activity of this drug.